Search

everythinglearnresearchcommunity

for

Search:↓

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

New microspheres help heal skin wounds and regrow hair without scarring.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness but cost nearly as much as the proven treatment, minoxidil.

Shi-Bi-Man helps hair regrowth by activating the FGF pathway in cells.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The herbal hair oil effectively promotes hair growth, nourishes the scalp, and prevents dandruff.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.